New live biotherapeutics will require regulatory and scientific innovation: the importance of a defined regulatory framework

Live Biotherapeutics developers will need to incorporate gold-standard pharmaceutical development techniques and approaches in order to reach market and patients in need The Pharmabiotic Research Institute (PRI), Europe’s only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled “Live biotherapeutic products: the importance of a defined […]

More